AVAlex B. Valadka

Alex B. Valadka

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Alex B. Valadka has a total of 199 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Current management of traumatic intracranial hypertension: What you need to know

    by Alex B. Valadka, Brooke Brady, Linda A. Dultz, Rocco A. Armonda, Andrii Sirko

    Intracranial hypertension (ICH) has long been recognized as a major challenge in the management of patients with severe traumatic brain injury. Although it has become widely accepted that patients with unremarkable brain computed tomography scans may not require invasive intracranial pressure (ICP) monitoring, the threshold for using such monitoring in other severe traumatic brain injury patients should be low. Intraparenchymal monitors and external ventricular drains are both effective monitoring techniques. No specific prophylactic interventions are available to prevent ICH. Instead, initial management focuses on maintaining physiological parameters in the normal range and intervening promptly when deviations occur. Management of elevated intracranial pressure proceeds along a series of interventions that begins with the least invasive and least complex measures and progressively escalates to those with greater scope and risk. However, the sequence of these steps is not rigorously defined, and considerable latitude may be exercised according to a specific patient's individual situation. Choosing the appropriate therapies for different patients requires the clinician to have a deep understanding of the pathophysiology of ICH. ( J Trauma Acute Care Surg . 2026;100: 837–849. Copyright © 2026 Wolters Kluwer Health, Inc. All rights reserved.)


  • Open Access

    Consensus statement from the 2025 Delphi panel on cerebral microdialysis in critical care

    by Adel Helmy, Michael S. Baker, Patrick M. Chen, Aoife Quinn, Ibrahim Jalloh, Louise Roberts, Neeraj Badjatia, Antonio Belli, Martyn G. Boutelle, M. Ross Bullock, et al.

    Purpose: Secondary brain injury is a common cause of poor outcome after trauma, subarachnoid hemorrhage, and intracerebral hemorrhage, and optimizing treatment requires real-time insight into cerebral metabolism. Cerebral microdialysis (CMD) uniquely provides key related information, yet consensus on its use has not been updated since publication of the consensus statement from the 2014 International Microdialysis Forum. We aimed to assess expert consensus on the use of CMD in critical care and provide contemporary guidance to standardize practice and advance clinical implementation. Methods: We conducted a 3-round modified Delphi study with international experts in CMD and neurocritical care. Consensus was defined as ≥ 75% agreement among non-abstaining respondents, with a minimum of 30 non-abstaining respondents required per statement. Statements not reaching consensus were iteratively revised based on panelist feedback. Results: Forty of 67 invited experts (60%) from 9 countries participated. Sixty of 62 individual items achieved consensus (97%) across 9 domains: indications and patient selection, technical and procedural considerations, detecting deterioration and secondary injury, metabolic interpretation, treatment algorithms, glucose management, sampling frequency, core reporting items, and barriers to clinical implementation. Conclusion: This consensus statement provides updated, evidence-informed recommendations for the use of CMD in critical care. The panel reaffirmed many core recommendations from the 2014 consensus while making targeted advances: cautious extension of guidance to intracerebral hemorrhage, comprehensive reporting guidance addressing frequently omitted elements (19 items vs. 6 in 2014), and identification of 10 key barriers to routine clinical adoption.


  • Open Access

    History of tumor, spine, and trauma neurosurgery in Ukraine: growth and resilience

    by Oleksandr Strelko, Alex B. Valadka, Luke Tomycz, Rocco A. Armonda, Jonathan A. Forbes, Gregory W. J. Hawryluk, James T. Rutka, Andrii Sirko

    "History of tumor, spine, and trauma neurosurgery in Ukraine: growth and resilience" published on 09 May 2025 by American Association of Neurological Surgeons.


  • Surgical Treatment of Penetrating Wounds After Resuscitation study: a new classification system for penetrating injuries to the posterior fossa

    by Andrii Sirko, Jeffrey I. Traylor, William H. Hicks, Ghazal Yadav, Rocco A. Armonda, Alex B. Valadka

    OBJECTIVE: The goal of this retrospective study was to evaluate the new Surgical Treatment of Penetrating Wounds After Resuscitation (STOPWAR) posterior fossa penetrating traumatic brain injury (pTBI) classification scheme, which is based only on features of the projectile trajectory. METHODS: This retrospective investigation evaluated a consecutive series of 71 patients with penetrating posterior fossa injuries who arrived at Mechnikov Dnipropetrovsk Regional Clinical Hospital in Dnipro, Ukraine, between February 24, 2022, and May 2, 2024. Univariable and multivariable analyses were performed to examine the relationships between STOPWAR classification and 1-month mortality as well as 1-month outcome on the dichotomized Glasgow Outcome Scale (GOS). Other classification and prognostic schemes for patients with traumatic brain injury (TBI) were also evaluated. RESULTS: The 1-month mortality rate in this series was 21%. The STOPWAR classification scheme had an area under the receiver operating characteristic curve (AUC) of 0.9298 and OR of 4.054 (95% CI 2.287–9.126) for 1-month mortality and an AUC of 0.8373 and OR of 3.154 (95% CI 1.954–5.830) for 1-month dichotomized GOS outcome. This performance was comparable to that of the other TBI classification schemes that were evaluated. CONCLUSIONS: In the largest reported series of patients with posterior fossa pTBI, 1-month mortality was lower than that in other published series, suggesting that patients with military pTBI, which is caused primarily by shrapnel, may have a better outcome than those with civilian pTBI, most of whom have gunshot wounds. The STOPWAR classification system performed well. A major advantage of the STOPWAR scale is that it is based only on imaging findings and may be used when clinical examination is impossible or potentially inaccurate. The slightly worse performance of the STOPWAR scheme for GOS outcome than for mortality may reflect the inadequacy of using the GOS as an outcome metric at the early postinjury time point of 1 month. Unfortunately, more detailed outcome assessments at longer postinjury time intervals are currently not possible in Ukraine. These and other improvements in study design can be explored in future investigations, which may also evaluate the role of the STOPWAR scale in civilian pTBI patients and in casualties from other armed conflicts.


  • Open Access

    An island of mercy: An American Veteran's view from Ukraine

    by Rocco A. Armonda, Andrii Sirko, Alex B. Valadka

    In this narrative, a former American military neurosurgeon describes his collaboration with colleagues in eastern Ukraine. He started by collecting and shipping medical supplies and sharing information through virtual conferences and text messages, which culminated in his first in-person visit. He provides vignettes about the many struggles and triumphs of the hospital staff. He also reflects upon the state of American military preparedness for dealing with the unprecedented type of modern warfare taking place in Ukraine.

  • Concussions in Baseball Players

    by Bradley Guidry, Anthony J. Dragun, Alex Valadka


  • Open Access

    Wartime penetrating skull base trauma with unpredictable internal fragment ricochet and migration: illustrative case

    by Andrii Sirko, Alex Valadka, Rocco Armonda, Anthony J Dragun, Yurii Cherednychenko

    BACKGROUND: Transnasal transsphenoidal penetrating craniocerebral injury is very rare even in wartime. Cases with good outcomes are even less common. OBSERVATIONS: A 20-year-old male sustained multiple fragment wounds to his head and face from a landmine explosion. One metal fragment entered his right nostril, traversed the nasal septum and anterior sphenoid sinus, and ricocheted superiorly off the clivus. The fragment then traveled almost to the surface of the left parietal lobe. Subsequently, under its own weight, it migrated back down its original track. The patient suffered cerebrospinal fluid rhinorrhea, pneumocephalus, and right-sided hemiparesis. Digital subtraction angiography was followed by microscopic transnasal skull base reconstruction supplemented by external lumbar drainage. Follow-up brain computed tomogrpahy showed further metallic fragment migration through the ventricular system. The fragment was removed through a transcortical approach. The patient’s neurological examination and brain magnetic resonance imaging results demonstrated good recovery. LESSONS: The absence of external signs of deep injuries does not exclude the presence of a penetrating craniocerebral injury. Metal fragments may undergo ricochet and internal migration in both the brain parenchyma and the ventricular system. Timely diagnosis including three-dimensional reconstruction of a projectile’s trajectory may facilitate appropriate surgical planning in complex cases. Intraventricular fragment migration may necessitate microsurgical removal. https://thejns.org/doi/10.3171/CASE24128


  • Isolated Traumatic Subarachnoid Hemorrhage on Head Computed Tomography Scan May Not Be Isolated: A Transforming Research and Clinical Knowledge in Traumatic Brain Injury Study (TRACK-TBI) Study

    by John K. Yue, Esther L. Yuh, Mahmoud M. Elguindy, Xiaoying Sun, Thomas A. van Essen, Hansen Deng, Patrick J. Belton, Gabriela G. Satris, Justin C. Wong, Alex B. Valadka, et al.

    Isolated traumatic subarachnoid hemorrhage (tSAH) after traumatic brain injury (TBI) on head computed tomography (CT) scan is often regarded as a “mild” injury, with reduced need for additional workup. However, tSAH is also a predictor of incomplete recovery and unfavorable outcome. This study aimed to evaluate the characteristics of CT-occult intracranial injuries on brain magnetic resonance imaging (MRI) scan in TBI patients with emergency department (ED) arrival Glasgow Coma Scale (GCS) score 13-15 and isolated tSAH on CT. The prospective, 18-center Transforming Research and Clinical Knowledge in Traumatic Brain Injury Study (TRACK-TBI; enrollment years 2014-2019) enrolled participants who presented to the ED and received a clinically-indicated head CT within 24 h of TBI. A subset of TRACK-TBI participants underwent venipuncture within 24 h for plasma glial fibrillary acidic protein (GFAP) analysis, and research MRI at 2-weeks post-injury. In the current study, TRACK-TBI participants age ≥17 years with ED arrival GCS 13-15, isolated tSAH on initial head CT, plasma GFAP level, and 2-week MRI data were analyzed. In 57 participants, median age was 46.0 years [quartile 1 to 3 (Q1-Q3): 34-57] and 52.6% were male. At ED disposition, 12.3% were discharged home, 61.4% were admitted to hospital ward, and 26.3% to intensive care unit. MRI identified CT-occult traumatic intracranial lesions in 45.6% (26 of 57 participants; one additional lesion type: 31.6%; 2 additional lesion types: 14.0%); of these 26 participants with CT-occult intracranial lesions, 65.4% had axonal injury, 42.3% had subdural hematoma, and 23.1% had intracerebral contusion. GFAP levels were higher in participants with CT-occult MRI lesions compared with without (median: 630.6 pg/mL, Q1-Q3: [172.4-941.2] vs. 226.4 [105.8-436.1], p = 0.049), and were associated with axonal injury (no: median 226.7 pg/mL [109.6-435.1], yes: 828.6 pg/mL [204.0-1194.3], p = 0.009). Our results indicate that isolated tSAH on head CT is often not the sole intracranial traumatic injury in GCS 13-15 TBI. Forty-six percent of patients in our cohort (26 of 57 participants) had additional CT-occult traumatic lesions on MRI. Plasma GFAP may be an important biomarker for the identification of additional CT-occult injuries, including axonal injury. These findings should be interpreted cautiously given our small sample size and await validation from larger studies.


  • Use of MRI in patients with severe diffuse traumatic brain injury: A matched National Trauma Data Bank analysis

    by Sai Chilakapati, Anthony J. Bs Dragun, Ryan G. Chiu, Keith M. George, Alex B. Valadka

    OBJECTIVE: Magnetic resonance imaging (MRI) is increasingly used to evaluate patients with diffuse traumatic brain injury (dTBI). However, the utility of early MRI is understudied. We hypothesize that early MRI patients will have increased length of stay but no changes in intracranial pressure (ICP) management or disposition. METHODS: The 2019 National Trauma Data Bank was queried for patients with dTBI and Glasgow Coma Scale score ≤8. Extra-axial and focal intra-axial hemorrhages were excluded. Clinical characteristics were controlled for. Patients with and without MRI were compared for ICP management, outcome, mortality, and disposition. A propensity score matching algorithm was used to create a 1:1 match cohort. RESULTS: In 2568 patients, MRI was less common in severe dTBI patients with clear reasons for poor examination, including bilaterally unreactive pupils or midline shift. After matching, 501 patients who underwent MRI within 1 week were compared with 501 patients without MRI. Magnetic resonance imaging patients had longer intensive care unit stays (11.6 ± 9.6 vs. 13.4 ± 9.5, p < 0.01; 95% confidence interval [95% CI], −3.03 to −0.66). There was no difference between groups in ICP monitor (23.6% vs. 27.3%; p = 0.17; 95% CI, −0.09 to 0.02) or ventriculostomy placement (13.6% vs. 13.2%, p = 0.85; 95% CI, −0.04 to 0.05) or in withdrawal of care (15.0% vs. 18.6%, p = 0.12; 95% CI, −0.08 to 0.01). MRI patients were more likely to be discharged to inpatient rehabilitation (42.9% vs. 33.5%; p < 0.01; 95% CI, 0.03–0.15) but not to home (9.4% vs. 9.0%; p = 0.83; 95% CI, −0.03 to 0.04). CONCLUSION: The decision to pursue early brain MRI may be driven by lack of obvious reasons for a patient's poor neurologic status. MRI patients had longer intensive care unit stays but no difference in rates of placement of ICP monitors or ventriculostomies or withdrawal of care. Further study is required to define the role of early MRI in dTBI patients. LEVEL OF EVIDENCE: Prognostic and Epidemiological; Level IV


  • Open Access

    Neuroworsening in the Emergency Department Is a Predictor of Traumatic Brain Injury Intervention and Outcome: A TRACK-TBI Pilot Study

    by John K. Yue, Nishanth Krishnan, John H. Kanter, Hansen Deng, David O. Okonkwo, Ava M. Puccio, Debbie Y. Madhok, Patrick J. Belton, Britta E. Lindquist, Gabriela G. Satris, et al.

    Introduction: Neuroworsening may be a sign of progressive brain injury and is a factor for treatment of traumatic brain injury (TBI) in intensive care settings. The implications of neuroworsening for clinical management and long-term sequelae of TBI in the emergency department (ED) require characterization. Methods: Adult TBI subjects from the prospective Transforming Research and Clinical Knowledge in Traumatic Brain Injury Pilot Study with ED admission and disposition Glasgow Coma Scale (GCS) scores were extracted. All patients received head computed tomography (CT) scan p < 0.001). Neuroworsening subjects had higher likelihoods of cranial surgery (56.3%/3.5%), intracranial pressure (ICP) monitoring (62.5%/2.6%), in-hospital mortality (37.5%/0.6%), and unfavorable 3- and 6-month outcome (58.3%/4.9%; 53.8%/6.2%; all p < 0.001). On multivariable analysis, neuroworsening predicted surgery (mOR = 4.65 [1.02–21.19]), ICP monitoring (mOR = 15.48 [2.92–81.85], and unfavorable 3- and 6-month outcome (mOR = 5.36 [1.13–25.36]; mOR = 5.68 [1.18–27.35]). Conclusions: Neuroworsening in the ED is an early indicator of TBI severity, and a predictor of neurosurgical intervention and unfavorable outcome. Clinicians must be vigilant in detecting neuroworsening, as affected patients are at increased risk for poor outcomes and may benefit from immediate therapeutic interventions.